By 
Zambia’s medicines regulator has recalled two batches of eye-drop products manufactured in India and Zimbabwe after they failed selected quality tests.
The Zambia Medicines Regulatory Authority (ZAMRA) said the recall covered batch LAHLE03629 of Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% (5ml) made in India, and batch LHLE03628 of Brinzolamide Ophthalmic Suspension USP 1% (5ml) made in Zimbabwe.
In a public alert issued in Lusaka on Thursday, ZAMRA Director General, Makomani Siyanga, said the affected batches showed “minimal differences” from other batches during initial laboratory checks, but were later found to be non-compliant.
Read More: Zambia, Zimbabwe sign pact to strengthen regulation of medical products
“Further investigations by the Authority are ongoing to establish the source of the products,” Siyanga said in the notice dated Feb. 6, 2026.
He urged health facilities, pharmacies and consumers to quarantine the products and return them to suppliers or the point of purchase, and warned against using or selling the substandard eye drops.
WARNING! All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express permission from ZAMBIA MONITOR.
Comments